Risk of dangerous blood clots linked to moderate COVID-19; high-dose blood thinner can prevent clots - Reuters
Dangerous blood clots can occur in moderate COVID-19.In hospitalized, moderately ill COVID-19 patients who have high levels of the d-dimer protein in their blood - indicating a higher-than-average risk for dangerous blood clots - treatment with high doses of the blood thinner low-molecular weight heparin (LMWH) significantly reduced the odds of clot formation and death, according to data from a clinical trial.The researchers said they launched the trial "because we saw patients getting blood clots and dying in front of us while on standard doses of preventative heparin," said study leader Dr.
that d-dimer levels more than four times the upper limit of normal are able to predict a very high-risk group of hospitalized COVID-19 patients - and giving therapeutic doses of heparin in these patients works," Spyropoulos said